Found 100 Enz. Inhib. hit(s) with all data for entry = 10222 TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataKi: 86nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataKi: 91nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataKi: 98nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataKi: 100nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataKi: 101nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataKi: 101nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
3D Structure (crystal)TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataKi: 114nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataKi: 127nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataKi: 184nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataKi: 186nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataKi: 276nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataKi: 343nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataKi: 657nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 112nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 130nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetCasein kinase I isoform delta(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 130nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 131nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 162nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 162nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 175nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 185nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 185nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 188nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 189nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 191nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 215nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 224nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 235nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 236nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 238nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 240nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 264nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 282nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetCasein kinase I isoform delta(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 284nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 289nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 307nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetCasein kinase I isoform delta(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 369nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 369nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetCasein kinase I isoform delta(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 403nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 408nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 412nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 419nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 456nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 481nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 481nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 518nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 520nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 526nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 543nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
The Trustees Of Columbia University In The City Of New York
US Patent
The Trustees Of Columbia University In The City Of New York
US Patent
Affinity DataIC50: 669nMAssay Description:The concentration dependent ability of compounds to inhibit human p38α MAPK, p38β MAPK and CK-1δ were done essentially as described in...More data for this Ligand-Target Pair
